Literature DB >> 16725248

Hippocampal 1H MRS in first-episode bipolar I patients.

Murad Atmaca1, Hanefi Yildirim, Huseyin Ozdemir, A Kursad Poyraz, Ertan Tezcan, Erkin Ogur.   

Abstract

Based on earlier structural and functional neuroimaging studies, we specifically wanted to assess N-acetylaspartate (NAA), choline-containing compounds (CHO), and creatine+phosphocreatine (CRE) levels in brain hippocampus previously demonstrated to be involved in the pathophysiology of bipolar disorder which have not been evaluated in first-episode patients. Twelve patients meeting DSM-IV criteria for bipolar disorder who consecutively applied to our department and 12 healthy controls were studied. The patients and controls underwent proton magnetic resonance spectroscopy ((1)H MRS), and measures of NAA, CHO, and CRE in hippocampal regions were obtained. ANOVA revealed in the hippocampus a significant effect of diagnosis for NAA/CRE and for NAA/CHO but not for CHO/CRE. Post hoc analysis showed that patients had a significant bilateral reduction of NAA/CRE and of NAA/CHO. No significant correlation was found between hippocampus volume and ratio measures. Correlation analyses exhibited significant correlation between NAA values and the YMRS for both side of the hippocampus, but not any other clinical variables (age, age at onset, and duration of illness). In summary, hippocampal neuronal abnormalities seem to be present at the onset of bipolar I disorder. These data suggest that neuronal abnormalities in hippocampus may be associated with the severity of bipolar I disorder. As these data were obtained in patients in their first-episode (all the patients were manic), they cannot be explained by chronicity of illness or pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16725248     DOI: 10.1016/j.pnpbp.2006.03.032

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  12 in total

Review 1.  Medication effects in neuroimaging studies of bipolar disorder.

Authors:  Mary L Phillips; Michael J Travis; Andrea Fagiolini; David J Kupfer
Journal:  Am J Psychiatry       Date:  2008-02-01       Impact factor: 18.112

Review 2.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

3.  Structure-function associations in hippocampus in bipolar disorder.

Authors:  Lara G Chepenik; Fei Wang; Linda Spencer; Marisa Spann; Jessica H Kalmar; Fay Womer; E Kale Edmiston; Brian Pittman; Hilary P Blumberg
Journal:  Biol Psychol       Date:  2012-02-10       Impact factor: 3.251

4.  Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.

Authors:  Tomas Hajek; Michael Bauer; Andrea Pfennig; Jeffrey Cullis; Jana Ploch; Claire O'Donovan; Georg Bohner; Randolf Klingebiel; L Trevor Young; Glenda M Macqueen; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2012-05       Impact factor: 6.186

5.  Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.

Authors:  Alexa J Stern; Antonina A Savostyanova; Aaron Goldman; Alan S Barnett; Jan Willem C van der Veen; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger; Stefano Marenco
Journal:  Biol Psychiatry       Date:  2008-08-15       Impact factor: 13.382

Review 6.  Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

Authors:  Rafael T de Sousa; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Ther Targets       Date:  2014-07-24       Impact factor: 6.902

7.  Hippocampal neurochemical pathology in patients with panic disorder.

Authors:  Murad Atmaca; Hanefi Yildirim; M Gurkan Gurok; Muammer Akyol; Filiz Koseoglu
Journal:  Psychiatry Investig       Date:  2012-04-30       Impact factor: 2.505

8.  Altered neurochemical ingredient of hippocampus in patients with bipolar depression.

Authors:  Murad Atmaca; Hanefi Yildirim
Journal:  Depress Res Treat       Date:  2012-03-01

9.  Neurochemical metabolites in the medial prefrontal cortex in bipolar disorder: A proton magnetic resonance spectroscopy study.

Authors:  Osman Ozdel; Demet Kalayci; Gülfizar Sözeri-Varma; Yilmaz Kiroğlu; Selim Tümkaya; Tugçe Toker-Uğurlu
Journal:  Neural Regen Res       Date:  2012-12-25       Impact factor: 5.135

10.  Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder.

Authors:  D J Bond; L E Silveira; E L MacMillan; I J Torres; D J Lang; W Su; W G Honer; R W Lam; L N Yatham
Journal:  Transl Psychiatry       Date:  2017-03-28       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.